Indian contract development and manufacturing organization Piramal Pharma Solutions is to bolster its manufacturing capabilities after agreeing to acquire a site from US-based G&W Laboratories, with plans to offer high-potency drug manufacturing capabilities in the future.
Piramal Pharma Solutions is to have “solid oral dose capabilities on three continents,” after agreeing to acquire G&W Laboratories’ US solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania, to add to existing manufacturing in the UK and India.
The acquisition, for which financial details were not disclosed and which is subject to customary closing conditions, “broadens the offering...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
